Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia
Status:
Completed
Trial end date:
2019-11-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the pharmacokinetics of HQP1351 in participants
with resistant chronic myeloid leukemia (CML) in chronic phase (CP) after high-fat and
fasting meals separately（Selection of high-fat meal spectrum：《The Food - Effect
Bioavailability and Fed Bioequivalence Studies》high fat diet should be 800-1000 kcal heat.).